Drug & medication recalls Moderate risk

Losartan Potassium 100 mg recalled over manufacturing violations

Recall date
April 30, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Direct Rx recalls Losartan Potassium 100 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 6…
Recall number
D-0018-2021
FDA classification
Class II
Brand / firm
Direct Rx
Sold / distributed
GA

Why it was recalled

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level per manufacturer

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Losartan Potassium 100 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-952-30

Get recall alerts

Free email alert whenever Direct Rx has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Direct Rx